Airflow obstruction and exercise.
暂无分享,去创建一个
[1] C. Cooper,et al. A review of the GOLD guidelines for the diagnosis and treatment of patients with COPD , 2008, International journal of clinical practice.
[2] David M. Shade,et al. Exercise Testing in Severe Emphysema: Association with Quality of Life and Lung Function , 2008, COPD.
[3] A. Ries. ACCP/AACVPR evidence-based guidelines for pulmonary rehabilitation. Round 3: another step forward. , 2007, Journal of cardiopulmonary rehabilitation and prevention.
[4] Sean Keenan,et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update. , 2007, Canadian respiratory journal.
[5] C. Cooper. The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function. , 2006, The American journal of medicine.
[6] D. Halpin,et al. Chronic obstructive pulmonary disease: the disease and its burden to society. , 2006, Proceedings of the American Thoracic Society.
[7] G. Kwakkel,et al. Training with inspiratory pressure support in patients with severe COPD , 2006, European Respiratory Journal.
[8] R. Casaburi,et al. Exercise Training Decreases Ventilatory Requirements and Exercise-Induced Hyperinflation at Submaximal Intensities in Patients With COPD , 2005 .
[9] F. Maltais,et al. Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD. , 2005, Chest.
[10] Y. Lacasse,et al. Randomised trial of ambulatory oxygen in oxygen-dependent COPD , 2005, European Respiratory Journal.
[11] Thierry Troosters,et al. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. , 2005, American journal of respiratory and critical care medicine.
[12] C. Goldsmith,et al. Lung Volume Reduction Surgery vs Medical Treatment , 2005 .
[13] R. L. Berger,et al. Lung volume reduction surgery vs medical treatment: for patients with advanced emphysema. , 2005, Chest.
[14] D. Hansell,et al. Effect of bronchoscopic lung volume reduction on dynamic hyperinflation and exercise in emphysema. , 2005, American journal of respiratory and critical care medicine.
[15] R. Casaburi,et al. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. , 2005, Chest.
[16] P. Palange,et al. Effect of heliox on lung dynamic hyperinflation, dyspnea, and exercise endurance capacity in COPD patients. , 2004, Journal of applied physiology.
[17] P. Frith,et al. Perceived Locus of Symptom Limitation during Constant Work Rate Cycle Ergometry in COPD Patients Treated with Tiotropium , 2004 .
[18] R. Kaplan,et al. Measurement of health-related quality of life in the national emphysema treatment trial. , 2004, Chest.
[19] D. O’Donnell,et al. Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease , 2004, European Respiratory Journal.
[20] A. Foresi,et al. Effect of heliox breathing on dynamic hyperinflation in COPD patients. , 2004, Chest.
[21] B. Make,et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD , 2004, European Respiratory Journal.
[22] W. MacNee,et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper , 2004, European Respiratory Journal.
[23] E. Clini,et al. Occupational Therapy and Pulmonary Rehabilitation of Disabled COPD Patients , 2004, Respiration.
[24] D. Forman,et al. Delays in managing lung cancer. , 2004, Thorax.
[25] R. Zuwallack,et al. Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes. , 2003, Chest.
[26] R. Adams,et al. Sustained improvements in dyspnea and pulmonary function 3 to 5 years after lung volume reduction surgery. , 2003, Chest.
[27] Steven Piantadosi,et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. , 2003, The New England journal of medicine.
[28] M. Tsukino,et al. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. , 2003, American journal of respiratory and critical care medicine.
[29] D. Mannino,et al. Chronic obstructive pulmonary disease surveillance--United States, 1971-2000. , 2002, Respiratory care.
[30] L. Forkert,et al. Response of lung volumes to inhaled salbutamol in a large population of patients with severe hyperinflation. , 2002, Chest.
[31] Victor F. Froelicher,et al. Exercise capacity and mortality among men referred for exercise testing. , 2002, The New England journal of medicine.
[32] T. Storer,et al. Exercise in chronic pulmonary disease: resistance exercise prescription. , 2001, Medicine and science in sports and exercise.
[33] C. Cooper. Exercise in chronic pulmonary disease: limitations and rehabilitation. , 2001, Medicine and science in sports and exercise.
[34] S. M. Lee,et al. Dose-response effect of oxygen on hyperinflation and exercise endurance in nonhypoxaemic COPD patients. , 2001, The European respiratory journal.
[35] D. O’Donnell. Ventilatory limitations in chronic obstructive pulmonary disease. , 2001, Medicine and science in sports and exercise.
[36] D. Tashkin,et al. Gender bias in the diagnosis of COPD. , 2001, Chest.
[37] J. Sunyer,et al. Epidemiology of chronic obstructive pulmonary disease. , 2001, The European respiratory journal.
[38] P. Barnes,et al. Chronic obstructive pulmonary disease. , 2000, The New England journal of medicine.
[39] M. Morgan,et al. Randomized controlled trial of ambulatory oxygen and an ambulatory ventilator on endurance exercise in COPD. , 2000, Respiratory medicine.
[40] E. Prescott. Tobacco-related diseases: the role of gender. An epidemiologic study based on data from the Copenhagen Centre for Prospective Population Studies. , 2000, Danish medical bulletin.
[41] P. Jones,et al. Physiological and symptom determinants of exercise performance in patients with chronic airway obstruction. , 2000, Respiratory medicine.
[42] N. Payne,et al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial , 2000, The Lancet.
[43] D. O’Donnell,et al. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.
[44] D. O’Donnell,et al. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.
[45] F. Maltais,et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.
[46] R. Casaburi,et al. Physiologic benefits of exercise training in rehabilitation of patients with severe chronic obstructive pulmonary disease. , 1997, American journal of respiratory and critical care medicine.
[47] D. O’Donnell,et al. Qualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysiologic mechanisms. , 1997, American journal of respiratory and critical care medicine.
[48] M. Belman,et al. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. , 1996, American journal of respiratory and critical care medicine.
[49] V. Jounieaux,et al. Oxygen cost of breathing in patients with emphysema or chronic bronchitis in acute respiratory failure. , 1995, American journal of respiratory and critical care medicine.
[50] R. Viggiano,et al. Effect of mild-to-moderate airflow limitation on exercise capacity. , 1991, Journal of applied physiology.
[51] H. Chrystyn,et al. Dose response relation to oral theophylline in severe chronic obstructive airways disease. , 1988, BMJ.
[52] R. Peto,et al. The natural history of chronic airflow obstruction. , 1977, British medical journal.